Your browser doesn't support javascript.
loading
Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates.
Stein, Derek R; Warner, Bryce M; Audet, Jonathan; Soule, Geoff; Siragam, Vinayakumar; Sroga, Patrycja; Griffin, Bryan D; Leung, Anders; Grolla, Allen; Tierney, Kevin; Albietz, Alix; Kobasa, Darwyn; Musa, Abdulmajid S; Ahmad, Adama; Akinpelu, Afolabi M; Mba, Nwando; Rosenke, Rebecca; Scott, Dana P; Saturday, Greg; Ihekweazu, Chikwe; Safronetz, David.
Affiliation
  • Stein DR; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Warner BM; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Audet J; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Soule G; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Siragam V; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Sroga P; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • Griffin BD; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Leung A; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Grolla A; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Tierney K; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Albietz A; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Kobasa D; Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
  • Musa AS; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • Ahmad A; Nigerian Centre for Disease Control, Jabi, Abuja, Nigeria.
  • Akinpelu AM; Nigerian Centre for Disease Control, Jabi, Abuja, Nigeria.
  • Mba N; Nigerian Centre for Disease Control, Jabi, Abuja, Nigeria.
  • Rosenke R; Nigerian Centre for Disease Control, Jabi, Abuja, Nigeria.
  • Scott DP; Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton Montana, United States of America.
  • Saturday G; Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton Montana, United States of America.
  • Ihekweazu C; Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton Montana, United States of America.
  • Safronetz D; Nigerian Centre for Disease Control, Jabi, Abuja, Nigeria.
PLoS Pathog ; 17(10): e1009966, 2021 10.
Article in En | MEDLINE | ID: mdl-34634087
Nigeria continues to experience ever increasing annual outbreaks of Lassa fever (LF). The World Health Organization has recently declared Lassa virus (LASV) as a priority pathogen for accelerated research leading to a renewed international effort to develop relevant animal models of disease and effective countermeasures to reduce LF morbidity and mortality in endemic West African countries. A limiting factor in evaluating medical countermeasures against LF is a lack of well characterized animal models outside of those based on infection with LASV strain Josiah originating form Sierra Leone, circa 1976. Here we genetically characterize five recent LASV isolates collected from the 2018 outbreak in Nigeria. Three isolates were further evaluated in vivo and despite being closely related and from the same spatial / geographic region of Nigeria, only one of the three isolates proved lethal in strain 13 guinea pigs and non-human primates (NHP). Additionally, this isolate exhibited atypical pathogenesis characteristics in the NHP model, most notably respiratory failure, not commonly described in hemorrhagic cases of LF. These results suggest that there is considerable phenotypic heterogeneity in LASV infections in Nigeria, which leads to a multitude of pathogenesis characteristics that could account for differences between subclinical and lethal LF infections. Most importantly, the development of disease models using currently circulating LASV strains in West Africa are critical for the evaluation of potential vaccines and medical countermeasures.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease Models, Animal / Lassa Fever / Lassa virus Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: PLoS Pathog Year: 2021 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease Models, Animal / Lassa Fever / Lassa virus Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: PLoS Pathog Year: 2021 Type: Article Affiliation country: Canada